Parliamentary Search

Written question asked by Lord Avebury (Liberal Democrat) on Tuesday, 3 November 2015, in the House of Lords. It was due for an answer on Tuesday, 17 November 2015. It was answered by Lord Prior of Brampton (Conservative) on Thursday, 12 November 2015 on behalf of the Department of Health.

Stem Cells

Question

To ask Her Majesty’s Government what progress has been made in implementing the recommendations of the 2014 report of the UK Stem Cell Strategy Oversight Committee on the future of unrelated donor stem cell transplantation in the United Kingdom.

Answer

The Government continues to take forward work to deliver the recommendations in the 2014 report. We remain committed to improving stem cell transplantation services and doing all we can to help those in need of a transplant to find a suitable donor.


Since 2011, the Department has provided its delivery partners, NHS Blood and Transplant and the Anthony Nolan, a total of £16 million in additional, new funding to improve stem cell transplantation services in the United Kingdom. A further £3 million investment was announced in March 2015.


This funding has led to a tangible improvement in the availability of stem cells in the UK and the achievements include:


- More UK patients received a stem cell transplant in 2014 than ever before;


- Over 60% of black, Asian and minority ethnic (BAME) patients are now able to find a well matched donor compared to only 40% in 2010;


- A single unified bone marrow donor registry has been created streamlining the provision of stem cells and reducing the time to provide cells from adult donors;


- The proportion of patients receiving cord blood from UK donors has significantly increased; and


- An increase in UK patients receiving a transplant from 802 in 2010/11 to 1,060 in 1013/14. The increased use of UK-sourced stem cells has meant that more donors than ever are available to donate leading to a significant cost saving by reducing the need to import stem cells.



Secondary information

Type
Written question
Reference
HL3222
Session
2015-16
Subjects
Medical treatments Stem cells
Link
View this Written question on www.parliament.uk